ACRV(Acrivon Therapeutics, Inc.) 的内部人交易:医疗保健,生物技术。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 交易日 | 姓名 | 职务 | 类型 | 股数 | 价格 |
|---|---|---|---|---|---|
| 2026-11-17 | Peterson Katharine | Chief Accounting Officer | 公开市场卖出 | 107 | $1.45 |
| 2026-11-17 | Miller Mary | Chief Legal Officer | 公开市场卖出 | 193 | $1.45 |
| 2026-11-17 | Gamelin Erick | Chief Development Officer | 公开市场卖出 | 416 | $1.45 |
| 2026-11-17 | Devroe Eric | Chief Operating Officer | 公开市场卖出 | 628 | $1.45 |
| 2026-11-17 | Blume-Jensen Peter | President and CEO | 公开市场卖出 | 504 | $1.45 |
| 2026-11-17 | Blume-Jensen Peter | President and CEO | 公开市场卖出 | 1,276 | $1.45 |
| 2026-10-22 | Miller Mary | Chief Legal Officer | 公开市场卖出 | 513 | $1.84 |
| 2026-10-05 | Miller Mary | Chief Legal Officer | 公开市场卖出 | 294 | $1.99 |
| 2026-08-25 | Blume-Jensen Peter | President and CEO | 公开市场卖出 | 14,036 | $2.21 |
| 2026-08-18 | Peterson Katharine | Chief Accounting Officer | 公开市场卖出 | 101 | $2.01 |
| 2026-08-18 | Miller Mary | Chief Legal Officer | 公开市场卖出 | 185 | $2.01 |
| 2026-08-18 | Gamelin Erick | Chief Development Officer | 公开市场卖出 | 400 | $2.01 |
| 2026-08-18 | Devroe Eric | Chief Operating Officer | 公开市场卖出 | 604 | $2.01 |
| 2026-08-18 | Blume-Jensen Peter | President and CEO | 公开市场卖出 | 484 | $2.01 |
| 2026-08-18 | Blume-Jensen Peter | President and CEO | 公开市场卖出 | 1,229 | $2.01 |
| 2026-08-04 | Levy Adam D. | Chief Financial Officer | 公开市场卖出 | 1,142 | $1.57 |
| 2026-07-21 | Miller Mary | Chief Legal Officer | 公开市场卖出 | 573 | $1.76 |
| 2026-01-14 | Blume-Jensen Peter | President and CEO | 公开市场买入 | 49,000 | $1.68 |
| 2026-01-14 | Levy Adam D. | Chief Financial Officer | 公开市场买入 | 8,832 | $1.70 |
| 2026-01-13 | Devroe Eric | Chief Operating Officer | 公开市场买入 | 10,000 | $1.72 |